Imlunestrant tosylate structure
|
Common Name | Imlunestrant tosylate | ||
---|---|---|---|---|
CAS Number | 2408840-41-3 | Molecular Weight | 696.71 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C36H32F4N2O6S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Imlunestrant tosylateImlunestrant (LY-3484356) tosylate is an orally active, potent and selective estrogen receptor degrader (SERD) with pure antagonistic properties. Imlunestrant tosylate results in sustained inhibition of ER-dependent gene transcription and cell growth. Imlunestrant tosylate can be used for the research of ER-positive (ER+) advanced breast cancer (aBC) and endometrial endometrioid cancer (EEC)[1][2]. |
Name | Imlunestrant tosylate |
---|
Description | Imlunestrant (LY-3484356) tosylate is an orally active, potent and selective estrogen receptor degrader (SERD) with pure antagonistic properties. Imlunestrant tosylate results in sustained inhibition of ER-dependent gene transcription and cell growth. Imlunestrant tosylate can be used for the research of ER-positive (ER+) advanced breast cancer (aBC) and endometrial endometrioid cancer (EEC)[1][2]. |
---|---|
Related Catalog | |
In Vitro | LY3484356 显示出良好药代动力学 (PK) 特性,包括在 ESR1 突变体中的抗肿瘤活性[1]。 |
References |
Molecular Formula | C36H32F4N2O6S |
---|---|
Molecular Weight | 696.71 |